Trade Aktis Oncology (AKTS) shares | Commission-free on Freetrade

Aktis Oncology$AKTS • Radiopharmaceuticals

$20.58

-18.87%(-$4.78)in the last month

The US market is currently closed. It will re-open at today from 14:30.

Stats

Get access to key stats

Sign up or log in to see key stats

US Market

About Aktis Oncology Inc

Aktis Oncology is a biotechnology company that discovers and develops a new class of targeted radiopharmaceuticals to treat a broad range of solid tumour cancers.

Health

Sector

Costs and charges

Analyst ratings & estimates

Advanced stock fundamentals

Sign up to get access to the latest stock fundamentals

Freetrade is your gateway to commission-free investing. Join over 1.6 million users using the Best online trading platform, as voted at the British Bank Awards for six years running.

Accounts

Stocks and Shares ISA Personal Pension General Investment

Customer Support

Help Complaints Here for you Investment risk

Resources

Dictionary Compare Plans

Company

About

Careers

Legal

T&Cs Privacy policy Cookie policy Order execution policy

Conflicts of interest Execution venues Keeping your money safe MIFIDPRU disclosures

Freetrade does not provide investment advice and individual investors should make their own decisions or seek independent advice. The value of investments can go down as well as up and you may receive back less than your original investment. Past performance is not a reliable indicator of future returns. Freetrade is a trading name of Freetrade Limited, which is a member firm of the London Stock Exchange and is authorised and regulated by the Financial Conduct Authority. Registered in England and Wales (no. 09797821).